Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BALPHARMA.NSthis companyBal Pharma Limited	₹83.18	15.3×	1.17×	0.31×	7.34×	72.1%	24.4%	6.7%	2.0%	7.6%	8.2%	-4.2%	1.94×	4.5×	1.24×	1.05×	2.0%	2	—	2	C+
ACHYUT.BOAchyut Healthcare Ltd.	₹8.09	532.32×	3.54×	17.22×	264.63×	-352.1%	16.8%	1.2%	3.3%	0.7%	0.2%	-5.6%	0.04×	-3.9×	30.1×	4.59×	0.0%	5	23.86	2	C+
DENISCHEM.BODenis Chem Lab Limited	₹59.95	9.33×	0.86×	0.43×	4.2×	21.6%	33.0%	6.0%	4.6%	9.2%	7.9%	1.9%	0.05×	0.19×	12.86×	2.7×	2.7%	5	4.36	2	C
FORTISMLR.BOFortis Malar Hospitals Limited	₹44.90	18.86×	2.27×	1,527.36×	-48.71×	-97.4%	-147.7%	-3083.8%	8096.7%	12.0%	-4.0%	0.0%	0×	0.82×	0×	11.33×	0.0%	3	—	2	C
KRKREBSBIO.BOKrebs Biochemicals & Industries Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
KREBSBIO.NSKrebs Biochemicals & Industries Limited	₹59.62	-5.06×	-0.53×	3.61×	-90.67×	-393.1%	27.5%	-50.0%	-71.4%	10.4%	-10.7%	-14.2%	-1.38×	-65.63×	-1.68×	0.09×	0.0%	4	-0.63	1	C-
Peer median	—	14.1×	1.56×	10.42×	-22.26×	-224.7%	22.2%	-24.4%	4.0%	9.8%	-1.9%	-2.8%	0.02×	-1.85×	6.43×	3.64×	0.0%	5	4.36	2	—